Predicting and monitoring cancer treatment response with diffusion‐weighted MRI
Open Access
- 23 June 2010
- journal article
- review article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 32 (1), 2-16
- https://doi.org/10.1002/jmri.22167
Abstract
An imaging biomarker that would provide for an early quantitative metric of clinical treatment response in cancer patients would provide for a paradigm shift in cancer care. Currently, nonimage based clinical outcome metrics include morphology, clinical, and laboratory parameters, however, these are obtained relatively late following treatment. Diffusion‐weighted MRI (DW‐MRI) holds promise for use as a cancer treatment response biomarker as it is sensitive to macromolecular and microstructural changes which can occur at the cellular level earlier than anatomical changes during therapy. Studies have shown that successful treatment of many tumor types can be detected using DW‐MRI as an early increase in the apparent diffusion coefficient (ADC) values. Additionally, low pretreatment ADC values of various tumors are often predictive of better outcome. These capabilities, once validated, could provide for an important opportunity to individualize therapy thereby minimizing unnecessary systemic toxicity associated with ineffective therapies with the additional advantage of improving overall patient health care and associated costs. In this report, we provide a brief technical overview of DW‐MRI acquisition protocols, quantitative image analysis approaches and review studies which have implemented DW‐MRI for the purpose of early prediction of cancer treatment response. J. Magn. Reson. Imaging 2010.Keywords
This publication has 67 references indexed in Scilit:
- From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid TumorsJournal of Nuclear Medicine, 2009
- The parametric response map is an imaging biomarker for early cancer treatment outcomeNature Medicine, 2009
- Diffusion-Weighted Magnetic Resonance Imaging for Predicting and Detecting Early Response to Chemoradiation Therapy of Squamous Cell Carcinomas of the Head and NeckClinical Cancer Research, 2009
- Cancer clinical trial outcomes: Any progress in tumour-size assessment?European Journal Of Cancer, 2009
- Breast Tumor Xenografts: Diffusion-weighted MR Imaging to Assess Early Therapy with Novel Apoptosis-Inducing Anti-DR5 AntibodyRadiology, 2008
- Functional Diffusion Map As an Early Imaging Biomarker for High-Grade Glioma: Correlation With Conventional Radiologic Response and Overall SurvivalJournal of Clinical Oncology, 2008
- Proton and sodium MRI assessment of emerging tumor chemotherapeutic resistanceNMR in Biomedicine, 2006
- The Functional Diffusion Map: An Imaging Biomarker for the Early Prediction of Cancer Treatment OutcomeNeoplasia, 2006
- Diffusion imaging for evaluation of tumor therapies in preclinical animal modelsMagnetic Resonance Materials in Physics, Biology and Medicine, 2004
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000